Opioid use disorder
J Strang, ND Volkow, L Degenhardt… - Nature reviews Disease …, 2020 - nature.com
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …
Retention in medication-assisted treatment for opiate dependence: a systematic review
Retention in medication-assisted treatment among opiate-dependent patients is associated
with better outcomes. This systematic review (55 articles, 2010–2014) found wide variability …
with better outcomes. This systematic review (55 articles, 2010–2014) found wide variability …
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …
use of, and dependence on, these drugs, and a wide range of interventions used to address …
The rise of multiple imputation: a review of the reporting and implementation of the method in medical research
P Hayati Rezvan, KJ Lee, JA Simpson - BMC medical research …, 2015 - Springer
Background Missing data are common in medical research, which can lead to a loss in
statistical power and potentially biased results if not handled appropriately. Multiple …
statistical power and potentially biased results if not handled appropriately. Multiple …
Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction
J Strang, T Groshkova, A Uchtenhagen… - The British Journal of …, 2015 - cambridge.org
BackgroundSupervised injectable heroin (SIH) treatment has emerged over the past 15
years as an intensive treatment for entrenched heroin users who have not responded to …
years as an intensive treatment for entrenched heroin users who have not responded to …
Addiction and brain reward and antireward pathways
EL Gardner - Chronic Pain and Addiction, 2011 - karger.com
Addictive drugs have in common that they are voluntarily self-administered by laboratory
animals (usually avidly), and that they enhance the functioning of the reward circuitry of the …
animals (usually avidly), and that they enhance the functioning of the reward circuitry of the …
Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial
E Oviedo-Joekes, D Guh, S Brissette… - JAMA …, 2016 - jamanetwork.com
Importance Diacetylmorphine hydrochloride (the active ingredient in heroin), delivered
under supervision, is effective for the treatment of severe opioid use disorder. However …
under supervision, is effective for the treatment of severe opioid use disorder. However …
Drug policy and the public good
T Babor - 2010 - books.google.com
Drug use represents a significant burden to public health through disease, disability and
social problems, and policy makers are becoming increasingly interested in how to develop …
social problems, and policy makers are becoming increasingly interested in how to develop …
Drug policy and the public good: evidence for effective interventions
Debates about which policy initiatives can prevent or reduce the damage that illicit drugs
cause to the public good are rarely informed by scientific evidence. Fortunately, evidence …
cause to the public good are rarely informed by scientific evidence. Fortunately, evidence …
BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity …
AR Lingford-Hughes, S Welch… - Journal of …, 2012 - journals.sagepub.com
The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …